EGFR / HER2

Catalog No.Inhibitor Name EGFR/ErbB1HER2/ErbB2ErbB3ErbB4Other
A10362Erlotinib HCl
****
A10422Gefitinib
**
A10514Lapatinib Ditosylate
**
**
*
c-Src
A10141Afatinib
****
**
A10638Neratinib
*
*
KDR,Src
A10211Canertinib
****
***
A11752Lapatinib
**
**
*
c-Src
A10047AG-490
*
*
JAK2
A10242CP-724714
**
A11051Dacomitinib
***
*
*
A10991WZ4002
****
***
A10116Sapitinib
***
***
HDAC,HDAC1,HDAC6
A10246CUDC-101
***
**
A11022AG-1478
***
A10702PD153035 HCl
****
Src,MEK/ERK,Raf
A10706Pelitinib
*
*
c-Abl,FLT1,c-Fms
A10043AEE788
****
***
*
MEK,LCK,VEGFR2
A11209AC480
**
*
*
A10678OSI-420
****
A10990WZ3146
****
A11155AST-1306
****
***
****
A13028Rociletinib
**
A11158Varlitinib
***
****
A13825Icotinib
***
MEK1,Aurora B,LCK
A11236TAK-285
**
**
*
Src,VEGFR,JAK3
A14049WHI-P154
***
A12725PD168393
****
A13755CNX-2006
**
PDGFR
A11949Tyrphostin 9
*
A15940AG-18
*
A15551AZD3759
****
A14985Afatinib Dimaleate
****
**
A13146CL-387785
****
A13044Poziotinib
***
***
**
A13681Osimertinib
**
BLK,ACK1,BRK
A15516AZ5104
****
***
A10992WZ8040
topo II
A10426Genistein
A12448Butein
mTOR
A10210Chrysophanic Acid
A10053Tyrphostin AG 879
*
Trk
A10286Daphnetin
*
PKC, PKA
A11027Irbinitinib (ARRY-380, ONT-380)
****
A11028AV-412
***
*
A11334BIBX 1382
****
*
A12867CGP-52411
*
A13588Tyrphostin AG 183
*
A15509WHI-P180
*
Cdk2
A10612Mubritinib (TAK 165)
****
A16413ARRY-380 (Irbinitinib)
****

Notes:
1.Hover mouse over " * " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " * " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

产品 51 到 100 共 105个

每页
页面:
  1. 1
  2. 2
  3. 3

设置降序顺序
  1. Mutated EGFR-IN-2

    Catalog No. A18565
    Quick View
    EGFR 抑制剂
    Mutated EGFR-IN-2 (compound 91) is a mutant-selective EGFR inhibitor extracted from patent WO2017036263A1, which potently inhibits single-mutant EGFR (T790M) and double-mutant EGFR (including L858R/T790M (IC50=??1nM) and ex19del/T790M), and can suppress activity of single gain-of-function mutant EGFR (including L858R and ex19del) as well. Mutated EGFR-IN-2 shows anti-tumor antivity. 了解更多
  2. Genistein

    Catalog No. A10425
    Quick View
    EGFR inhibitor
    Genistein, a soy isoflavone, is a multiple tyrosine kinases (e.g., EGFR) inhibitor which acts as a chemotherapeutic agent against different types of cancer, mainly by altering apoptosis, the cell cycle, and angiogenesis and inhibiting metastasis. 了解更多
  3. NSC 228155

    Catalog No. A16638
    Quick View
    EGFR activator
    NSC 228155 is an activator of EGFR, binds to the extracellular region of EGFR and enhance tyrosine phosphorylation of EGFR. 了解更多
  4. Epertinib

    Catalog No. A13777
    Quick View
    EGFR/HER2/HER4 inhibitor
    Epertinib is a potent, oral, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4, with IC50s of 1.48 nM, 7.15 nM and 2.49 nM, respectively. Epertinib shows potent antitumor activity. 了解更多
  5. EGFR-IN-2

    Catalog No. A12628
    Quick View
    EGFR inhibitor
    EGFR-IN-2 is a a noncovalent, irreversible, mutant-selective second generation EGFR inhibitor. 了解更多
  6. CHMFL-EGFR-202

    Catalog No. A12524
    Quick View
    EGFR inhibitor
    CHMFL-EGFR-202 is a potent, irreversible inhibitor of epidermal growth factor receptor (EGFR) mutant kinase, with IC50s of 5.3 nM and 8.3 nM for drug-resistant mutant EGFR T790M and WT EGFR kinases, respectively. 了解更多
  7. EGFR-IN-3

    Catalog No. A15847
    Quick View
    EGFR inhibitor
    EGFR-IN-3 is an epidermal growth factor receptor (EGFR) inhibitor. 了解更多
  8. Canertinib dihydrochloride

    Catalog No. A11344
    Quick View
    EGFR inhibitor
    Canertinib dihydrochloride (CI-1033 dihydrochloride) is a potent and irreversible EGFR inhibitor; inhibits cellular EGFR and ErbB2 autophosphorylation with IC50s of 7.4 and 9 nM. 了解更多
  9. Afatinib

    Catalog No. A18014
    Quick View
    EGFR inhibitor
    Afatinib (BIBW 2992) is an irreversible EGFR family inhibitor with IC50s of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively. 了解更多
  10. Tarloxotinib bromide

    Catalog No. A20849
    Quick View
    EGFR/HER2 inhibitor
    Tarloxotinib bromide (TH-4000) is an irreversible EGFR/HER2 inhibitor. 了解更多
  11. Mutant EGFR inhibitor

    Catalog No. A21144
    Quick View
    EGFR inhibitor
    Mutant EGFR inhibitor is a potent and selective mutant EGFR inhibitor extracted from patent WO 2013014448 A1; inhibits EGFRL858R, EGFRExon 19 deletion and EGFRT790M. 了解更多
  12. HS-10296 hydrochloride

    Catalog No. A21661
    Quick View
    EGFR/T790M inhibitor
    HS-10296 hydrochloride is an orally available and third-Generation inhibitor of epidermal growth factor receptor (EGFR)-activating mutations and T790M-resistant mutation with limited activity against wild-type EGFR. 了解更多
  13. AST2818 mesylate

    Catalog No. A21666
    Quick View
    EGFR inhibitor
    AST2818 mesylate is an EGFR inhibitor. 了解更多
  14. Nazartinib mesylate

    Catalog No. A21741
    Quick View
    covalent mutant-selective EGFR inhibitor
    Nazartinib mesylate (EGF816 mesylate) is a novel, covalent mutant-selective EGFR inhibitor, with Ki and Kinact of 31 nM and 0.222 min?1 on EGFR(L858R/790M) mutant, respectively. 了解更多
  15. Nazartinib S-enantiomer

    Catalog No. A21747
    Quick View
    EGFR inhibitor
    Nazartinib S-enantiomer (EGF816 S-enantiomer) is the less active S-enantiomer of Nazartinib. Nazartinib (EGF816) is an EGFR inhibitor. 了解更多
  16. Pyrotinib dimaleate

    Catalog No. A21756
    Quick View
    EGFR/HER2 dual inhibitor
    Pyrotinib dimaleate (SHR-1258 dimaleate) is a potent and selective EGFR/HER2 dual inhibitor with IC50 s of 13 and 38 nM, respectively. 了解更多
  17. Epertinib hydrochloride

    Catalog No. A21950
    Quick View
    EGFR, HER2 and HER4 inhibitor
    Epertinib hydrochloride is a potent, orally active, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4, with IC50s of 1.48 nM, 7.15 nM and 2.49 nM, respectively. Epertinib shows potent antitumor activity. 了解更多
  18. Lifirafenib

    Catalog No. A20988
    Quick View
    Raf/EGFR inhibitor
    Lifirafenib (BGB-283) is a novel and potent Raf Kinase and EGFR inhibitor with IC50 values of 23 and 29 nM for recombinant BRafV600E and EGFR, respectively. 了解更多
  19. (-)-Epigallocatechin gallate

    Catalog No. A10005
    Quick View
    Antioxidant, antiangiogenic, antitumor agent
    (-)-Epigallocatechin gallate是一种从绿茶中分离出来的强效抗氧化剂多酚类黄酮。 了解更多
  20. Pelitinib (EKB-569)

    Catalog No. A10706
    Quick View
    EGFR 抑制剂
    Pelitinib (EKB-569)是一种有效的,不可逆EGFR抑制剂,IC50为38.5 nM 了解更多
  21. Neratinib (HKI-272)

    Catalog No. A10638
    Quick View
    HER2 抑制剂
    Neratinib (HKI-272)是一种酪氨酸激酶抑制剂。 了解更多
  22. Canertinib (CI-1033)

    Catalog No. A10211
    Quick View
    HER2/ErbB2 抑制剂
    Canertinib (CI-1033)是一种不可逆的酪氨酸激酶抑制剂,对EGFR(IC50 0.8 nM),HER-2(IC50 19 nM)和ErbB-4(IC50 7 nM)具有活性。 了解更多
  23. BIBW2992 (Afatinib)

    Catalog No. A10141
    Quick View
    EGFR 抑制剂
    BIBW2992 (Afatinib)是酪氨酸激酶抑制剂(TKI),它不可逆地抑制人表皮生长因子受体2(Her2)和表皮生长因子受体(EGFR)激酶。 了解更多
  24. AZD8931 (Sapitinib)

    Catalog No. A10116
    Quick View
    pan-EGFR/pan-erbB 抑制剂
    AZD8931 (Sapitinib)是ErbB1,ErbB2和ErbB3受体信号传导的等效抑制剂。 了解更多
  25. Gefitinib (Iressa)

    Catalog No. A10422
    Quick View
    EGFR 抑制剂
    Gefitinib (Iressa)是一种EGFR抑制剂,可阻断靶细胞中表皮生长因子受体(EGFR)的信号传导。 了解更多
  26. Erlotinib HCl

    Catalog No. A10362
    Quick View
    EGFR 抑制剂
    Erlotinib hydrochloride是一种可逆的酪氨酸激酶抑制剂,作用于表皮生长因子受体(EGFR)。 了解更多
  27. AG-1478 (Tyrphostin AG-1478)

    Catalog No. A11022
    Quick View
    EGFR 抑制剂
    AG-1478 (Tyrphostin AG-1478)是EGFR激酶的抑制剂,IC50值为3 nM。 了解更多
  28. OSI-420

    Catalog No. A10678
    Quick View
    EGFR 抑制剂
    OSI-420 (Desmethyl Erlotinib,CP-473420)是一种口服活性EGFR酪氨酸激酶抑制剂,可通过抑制细胞间结构域来抑制受体酪氨酸激酶(TKs)。 了解更多
  29. CP-724714

    Catalog No. A10242
    Quick View
    HER2/ErbB2 抑制剂
    CP-724714是一种有效的,选择性HER2/ErbB2抑制剂,可抑制HER2激酶(IC50 3.8 ng/ml)。 了解更多
  30. AV-412

    Catalog No. A11028
    Quick View
    EGFR 抑制剂
    AV-412是一种EGFR / HER2抑制剂,可与表皮生长因子受体(EGFR)和人表皮生长因子受体2(HER2)结合并抑制其生长,这可能会导致肿瘤生长和血管生成受到抑制。 了解更多
  31. AG-490

    Catalog No. A10047
    Quick View
    EGFR 抑制剂
    AG 490是EGF受体酪氨酸激酶的选择性抑制剂 (EGFR和ErbB2的IC50值分别为2和13.5μM)。也抑制对Lck,Lyn,Btk,Syk和Src无活性的JAK2。 了解更多
  32. PF299804 (Dacomitinib, PF299)

    Catalog No. A11051
    Quick View
    EGFR 抑制剂
    PF299804是一种有效的,可口服的酪氨酸激酶人表皮生长因子受体(HER)1(EGFR),HER2和HER4不可逆抑制剂。 了解更多
  33. ARRY334543 (Varlitinib)

    Catalog No. A11158
    Quick View
    EGFR 抑制剂
    ARRY334543 (Varlitinib)是一种有效的EGFR和ErbB-2口服活性小分子抑制剂。 了解更多
  34. Genistin (Genistoside)

    Catalog No. A10426
    Quick View
    Genistin (Genistoside)是一种异黄酮,存在于许多饮食植物中,如大豆和葛根。显示出刺激体内雌激素依赖性乳腺癌细胞生长。 了解更多
  35. BMS-690514

    Catalog No. A11263
    Quick View
    VEGFR/EGFR 抑制剂
    BMS-690514是一种有效的选择性表皮生长因子受体(EGFR),HER2和HER4抑制剂,以及VEGF受体激酶。 了解更多
  36. Lapatinib (free base)

    Catalog No. A11752
    Quick View
    Lapatinib (free base)是一种双重酪氨酸激酶抑制剂,是一种有效的EGFR和ErbB2抑制剂,在无细胞试验中IC50分别为10.2和9.8 nM。可阻断HER2生长受体途径。 了解更多
  37. SU-5402

    Catalog No. A11558
    Quick View
    VEGFR/FGFR/EGFR 抑制剂?
    SU-5402是有效且选择性的血管内皮生长因子受体(VEGFR)和成纤维细胞生长因子受体(FGFR)抑制剂(在VEGFR2, FGFR1, PDGFRβ和EGFR处IC50值分别为0.02、0.03、0.51和> 100μM)。 了解更多
  38. PKC 412 (Midostaurin)

    Catalog No. A12650
    Quick View
    PKC 抑制剂
    PKC 412 (Midostaurin)是一种广谱蛋白激酶抑制剂。抑制常规PKC亚型α/β/γ,PDFRβ,VEGFR2,Syk,Flk-1,Flt3,Cdk1/B,PKA,c-Kit,c-Fgr,c-Src,VEGFR1和EGFR。显示有效的抗肿瘤活性。 了解更多
  39. Icotinib Hydrochloride

    Catalog No. A13718
    Quick View
    EGFR 抑制剂
    Icotinib hydrochloride是一种有效的特异性表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI),IC(50)为5 nM,包括EGFR(L858R),EGFR(L861Q),EGFR(T790M)和EGFR的突变体(T790M,L858R)。 了解更多
  40. AZD-9291 (Osimertinib)

    Catalog No. A13681
    Quick View
    EGFR 抑制剂
    AZD-9291 (Osimertinib)是第三代EGFR抑制剂,在临床前研究中显示出希望,并为已对现有EGFR抑制剂产生耐药性的晚期肺癌患者提供了希望。 了解更多
  41. Tyrphostin AG 183

    Catalog No. A13588
    Quick View
    EGFR 抑制剂
    Tyrphostin AG 183抑制EGFR(表皮生长因子受体)酪氨酸激酶(IC50 = 800 nM)。 了解更多
  42. CNX-2006

    Catalog No. A13755
    Quick View
    EGFR 抑制剂
    CNX-2006是一种有效的突变体选择性EGFR抑制剂,在具有激活性EGFR突变的细胞以及具有T790M突变的细胞中具有出色的体外活性。CNX-2006是CO-1686的原型,目前正在I期临床试验中,用于治疗EGFR突变型肺癌。 了解更多
  43. Icotinib

    Catalog No. A13825
    Quick View
    EGFR 抑制剂
    Icotinib是一种有效的特异性EGFR抑制剂,IC50为5 nM,包括EGFR,EGFR(L858R),EGFR(L861Q),EGFR(T790M)和EGFR(T790M,L858R)。 了解更多
  44. Afatinib dimaleate

    Catalog No. A14985
    Quick View
    EGFR 抑制剂
    Afatinib dimaleate是一种不可逆的EGFR/HER2抑制剂,对于HER2的体外药效IC50为14 nM。 了解更多
  45. Erlotinib mesylate

    Catalog No. A15081
    Quick View
    EGFR 抑制剂
    Erlotinib mesylate是人EGFR酪氨酸激酶的直接作用抑制剂,IC50为2 nM。 了解更多
  46. Gefitinib hydrochloride

    Catalog No. A15093
    Quick View
    EGFR 抑制剂
    Gefitinib hydrochloride是一种EGFR抑制剂,可通过靶细胞中的表皮生长因子受体(EGFR)中断信号传导。因此,它仅在EGFR突变和过度活跃的癌症中有效。 了解更多
  47. Vandetanib trifluoroacetate

    Catalog No. A15272
    Quick View
    VEGFR/EGFR 抑制剂
    Vandetanib trifluoroacetate是一种有效的VEGFR2抑制剂,IC50为40 nM。 了解更多
  48. WHI-P180

    Catalog No. A15509
    Quick View
    EGFR/Cdk2 抑制剂
    WHI-P180是有效的EGFR和Cdk2抑制剂,IC50分别为4.0和1.0 uM。 了解更多
  49. AZ5104

    Catalog No. A15516
    Quick View
    EGFR 抑制剂
    AZD-9291的去甲基代谢产物AZ5104是一种有效的EGFR抑制剂,对于EGFR(L858R/T790M),EGFR(L858R),EGFR(L861Q)和EGFR,IC50 <1 nM,6 nM,1 nM和25 nM EGFR(野生型)。 了解更多
  50. AZD3759

    Catalog No. A15551
    Quick View
    EGFR 抑制剂
    AZD3759是表皮生长因子受体(EGFR)的口服抑制剂。它结合并抑制EGFR以及某些突变形式的EGFR的活性。 了解更多

产品 51 到 100 共 105个

每页
页面:
  1. 1
  2. 2
  3. 3

设置降序顺序
Rewards